<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00494923</url>
  </required_header>
  <id_info>
    <org_study_id>DFG-SFB539-R</org_study_id>
    <nct_id>NCT00494923</nct_id>
  </id_info>
  <brief_title>Early Diagnosis, Pathogenesis and Progression of Open Angle Glaucoma</brief_title>
  <official_title>Glaucoma Including Pseudoexfoliation Syndrome (SFB 539)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Erlangen Glaucoma Registry is a clinical registry for cross sectional and longitudinal&#xD;
      observation of patients with open angle glaucoma (OAG) or glaucoma suspect, founded in 1991.&#xD;
      The primary aim is the evaluation of diagnostic and prognostic validity of morphometrical,&#xD;
      sensory and hemodynamical diagnostic procedures. No therapeutic studies are performed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose: Detection of onset and progression of structural and functional damage due to&#xD;
      glaucoma. Determination of rate and amount of progressive change due to glaucoma.&#xD;
      Characterisation of the relationship between structural and functional change over time.&#xD;
      Evaluation of predictive factors for the development and progression of glaucoma.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 1999</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Time to Disease Progression</measure>
    <time_frame>up to 20 years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">2500</enrollment>
  <condition>Primary Open Angle Glaucoma</condition>
  <condition>Secondary Open Angle Glaucoma</condition>
  <condition>Ocular Hypertension</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        primary care clinic&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Participants:&#xD;
&#xD;
          -  Patients: Primary open angle glaucoma, secondary open angle glaucoma due to PEX or&#xD;
             MDS, glaucoma suspects including ocular hypertension&#xD;
&#xD;
          -  Healthy volunteers (for cross sectional analysis only)&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Open anterior chamber angle&#xD;
&#xD;
          -  Best corrected visual acuity 0.7 or better&#xD;
&#xD;
          -  Age between 18 and 65 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any eye disease other than glaucoma&#xD;
&#xD;
          -  Systemic diseases with potentially ocular involvement (e.g., diabetes mellitus)&#xD;
&#xD;
          -  Myopic or hyperopic refractive error exceeding 8.0 diopters&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anselm G Juenemann, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>University Erlangen-Nuremberg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anselm G Juenemann, Prof.</last_name>
    <phone>**49-9131-8533001</phone>
    <email>anselm.juenemann@uk-erlangen.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Eye Hospital</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Laemmer, MD</last_name>
      <phone>**49-9131-8533001</phone>
      <email>robert.laemmer@uk-erlangen.de</email>
    </contact>
    <investigator>
      <last_name>Christian Y Mardin, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Folkert K Horn, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Georg Michelson, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Wessel JM, Horn FK, Tornow RP, Schmid M, Mardin CY, Kruse FE, Juenemann AG, Laemmer R. Longitudinal analysis of progression in glaucoma using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2013 May 1;54(5):3613-20. doi: 10.1167/iovs.12-9786.</citation>
    <PMID>23633657</PMID>
  </results_reference>
  <results_reference>
    <citation>Hoesl LM, Tornow RP, Schrems WA, Horn FK, Mardin CY, Kruse FE, Juenemann AG, Laemmer R. Glaucoma diagnostic performance of GDxVCC and spectralis OCT on eyes with atypical retardation pattern. J Glaucoma. 2013 Apr-May;22(4):317-24. doi: 10.1097/IJG.0b013e318237c8c5.</citation>
    <PMID>22027931</PMID>
  </results_reference>
  <results_reference>
    <citation>Schrems WA, Laemmer R, Hoesl LM, Horn FK, Mardin CY, Kruse FE, Tornow RP. Influence of atypical retardation pattern on the peripapillary retinal nerve fibre distribution assessed by scanning laser polarimetry and optical coherence tomography. Br J Ophthalmol. 2011 Oct;95(10):1437-41. doi: 10.1136/bjo.2010.190074. Epub 2011 Jan 17.</citation>
    <PMID>21242583</PMID>
  </results_reference>
  <results_reference>
    <citation>Hoesl LM, Mardin CY, Horn FK, Juenemann AG, Laemmer R. Influence of glaucomatous damage and optic disc size on glaucoma detection by scanning laser tomography. J Glaucoma. 2009 Jun-Jul;18(5):385-9. doi: 10.1097/IJG.0b013e3181845ffd.</citation>
    <PMID>19525729</PMID>
  </results_reference>
  <results_reference>
    <citation>Schrems WA, Mardin CY, Horn FK, Juenemann AG, Laemmer R. Comparison of scanning laser polarimetry and optical coherence tomography in quantitative retinal nerve fiber assessment. J Glaucoma. 2010 Feb;19(2):83-94. doi: 10.1097/IJG.0b013e3181a2fc0e.</citation>
    <PMID>19373100</PMID>
  </results_reference>
  <results_reference>
    <citation>Horn FK, Mardin CY, Laemmer R, Baleanu D, Juenemann AM, Kruse FE, Tornow RP. Correlation between local glaucomatous visual field defects and loss of nerve fiber layer thickness measured with polarimetry and spectral domain OCT. Invest Ophthalmol Vis Sci. 2009 May;50(5):1971-7. doi: 10.1167/iovs.08-2405. Epub 2009 Jan 17.</citation>
    <PMID>19151389</PMID>
  </results_reference>
  <results_reference>
    <citation>Laemmer R, Schroeder S, Martus P, Viestenz A, Mardin CY. Quantification of neuroretinal rim loss using digital planimetry in long-term follow-up of normals and patients with ocular hypertension. J Glaucoma. 2007 Aug;16(5):430-6. doi: 10.1097/IJG.0b013e31804a5e80.</citation>
    <PMID>17700284</PMID>
  </results_reference>
  <results_reference>
    <citation>Laemmer R, Horn FK, Viestenz A, Juenemann AG, Mardin CY. Influence of optic disc size on parameters of retinal nerve fiber analysis with laser scanning polarimetry. Graefes Arch Clin Exp Ophthalmol. 2006 May;244(5):603-8. doi: 10.1007/s00417-005-0125-1. Epub 2005 Sep 21.</citation>
    <PMID>16175374</PMID>
  </results_reference>
  <results_reference>
    <citation>Tornow RP, Schrems WA, Bendschneider D, Horn FK, Mayer M, Mardin CY, Lammer R. Atypical retardation patterns in scanning laser polarimetry are associated with low peripapillary choroidal thickness. Invest Ophthalmol Vis Sci. 2011 Sep 29;52(10):7523-8. doi: 10.1167/iovs.11-7557.</citation>
    <PMID>21862653</PMID>
  </results_reference>
  <results_reference>
    <citation>Horn FK, Lammer R, Mardin CY, Junemann AG, Michelson G, Lausen B, Adler W. Combined evaluation of frequency doubling technology perimetry and scanning laser ophthalmoscopy for glaucoma detection using automated classification. J Glaucoma. 2012 Jan;21(1):27-34. doi: 10.1097/IJG.0b013e3182027766.</citation>
    <PMID>21173705</PMID>
  </results_reference>
  <results_reference>
    <citation>Pasutto F, Krumbiegel M, Mardin CY, Paoli D, Lammer R, Weber BH, Kruse FE, Schlotzer-Schrehardt U, Reis A. Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1459-63. doi: 10.1167/iovs.07-1449.</citation>
    <PMID>18385063</PMID>
  </results_reference>
  <verification_date>December 2013</verification_date>
  <study_first_submitted>June 29, 2007</study_first_submitted>
  <study_first_submitted_qc>June 29, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2007</study_first_posted>
  <last_update_submitted>December 11, 2013</last_update_submitted>
  <last_update_submitted_qc>December 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 12, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
    <mesh_term>Ocular Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

